These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26560497)

  • 1. WITHDRAWN: S-adenosyl-L-methionine for alcoholic liver diseases.
    Rambaldi A; Gluud C
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD002235. PubMed ID: 26560497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-adenosyl-L-methionine for alcoholic liver diseases.
    Rambaldi A; Gluud C
    Cochrane Database Syst Rev; 2006 Apr; (2):CD002235. PubMed ID: 16625556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S-adenosyl-L-methionine for alcoholic liver diseases.
    Rambaldi A; Gluud C
    Cochrane Database Syst Rev; 2001; (4):CD002235. PubMed ID: 11687153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of adenosyl-methionine in alcoholic liver disease and intrahepatic cholestasis.
    Testino G; Leone S; Fagoonee S; Pellicano R
    Minerva Gastroenterol Dietol; 2018 Sep; 64(3):187-189. PubMed ID: 29521488
    [No Abstract]   [Full Text] [Related]  

  • 5. Role of S-adenosyl-L-methionine in the treatment of alcoholic liver disease: introduction and summary of the symposium.
    Purohit V; Russo D
    Alcohol; 2002 Jul; 27(3):151-4. PubMed ID: 12163142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S-adenosyl-L-methionine: its role in the treatment of liver disorders.
    Lieber CS
    Am J Clin Nutr; 2002 Nov; 76(5):1183S-7S. PubMed ID: 12418503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical efficacy of ademetionine "Heptor" in the therapy of alcohol-dependent liver disease].
    Tkachenko EI; Uspenskiĭ IuP; Skvortsova TE
    Eksp Klin Gastroenterol; 2008; (2):106-12. PubMed ID: 19145875
    [No Abstract]   [Full Text] [Related]  

  • 8. S-adenosyl-L-methionine treatment for alcoholic liver disease: a double-blinded, randomized, placebo-controlled trial.
    Medici V; Virata MC; Peerson JM; Stabler SP; French SW; Gregory JF; Albanese A; Bowlus CL; Devaraj S; Panacek EA; Richards JR; Halsted CH
    Alcohol Clin Exp Res; 2011 Nov; 35(11):1960-5. PubMed ID: 22044287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcoholic liver disease patients treated with S-adenosyl-L-methionine: an in-depth look at liver morphologic data comparing pre and post treatment liver biopsies.
    Le MD; Enbom E; Traum PK; Medici V; Halsted CH; French SW
    Exp Mol Pathol; 2013 Oct; 95(2):187-91. PubMed ID: 23886644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenetic therapy of alcoholic liver disease].
    Volchkova EV
    Eksp Klin Gastroenterol; 2002; (5):77-8, 129. PubMed ID: 12619584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-Adenosyl-L-methionine and alcoholic liver disease in animal models: implications for early intervention in human beings.
    Lieber CS
    Alcohol; 2002 Jul; 27(3):173-7. PubMed ID: 12163146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of nutritional therapy in alcoholic liver disease.
    Griffith CM; Schenker S
    Alcohol Res Health; 2006; 29(4):296-306. PubMed ID: 17718410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-Adenosyl Methionine (SAMe) for Depression in Adults.
    Wilson A
    Issues Ment Health Nurs; 2019 Aug; 40(8):725-726. PubMed ID: 30633610
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of S-adenosyl-L-methionine in the treatment of liver diseases.
    Lieber CS
    J Hepatol; 1999 Jun; 30(6):1155-9. PubMed ID: 10406198
    [No Abstract]   [Full Text] [Related]  

  • 15. S-adenosyl-L-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo-controlled study with negative results.
    Ribalta J; Reyes H; Gonzalez MC; Iglesias J; Arrese M; Poniachik J; Molina C; Segovia N
    Hepatology; 1991 Jun; 13(6):1084-9. PubMed ID: 2050326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments.
    Lieber CS
    Curr Gastroenterol Rep; 2004 Feb; 6(1):60-5. PubMed ID: 14720455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alcoholic liver disease and methionine metabolism.
    Kharbanda KK
    Semin Liver Dis; 2009 May; 29(2):155-65. PubMed ID: 19387915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early clinical double-blind study with S-adenosyl-L-methionine: a new potential antidepressant.
    Küfferle B; Grünberger J
    Adv Biochem Psychopharmacol; 1982; 32():175-80. PubMed ID: 7046363
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of the variations of S-adenosyl-L-methionine liver content on fat accumulation and ethanol metabolism in ethanol-intoxicated rats.
    Feo F; Pascale R; Garcea R; Daino L; Pirisi L; Frassetto S; Ruggiu ME; Di Padova C; Stramentinoli G
    Toxicol Appl Pharmacol; 1986 Apr; 83(2):331-41. PubMed ID: 2938307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral S-adenosyl-L-methionine on hepatic glutathione in patients with liver disease.
    Vendemiale G; Altomare E; Trizio T; Le Grazie C; Di Padova C; Salerno MT; Carrieri V; Albano O
    Scand J Gastroenterol; 1989 May; 24(4):407-15. PubMed ID: 2781235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.